Fundz

Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer

PRIVATEMay 20, 2024

Position

Chief Development Officer

Company

Chroma Medicine

Jenny Marlowe
jenny.marlowe@chromamedicine.com
BostonBiotechnologyHealth CareGeneticsTherapeutics

Description

Chroma Medicine, Inc. has announced the appointment of Jenny Marlowe, Ph.D., as the Company's Chief Development Officer

Quick answer

Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer (May 20, 2024). Chroma Medicine is based in Boston, Massachusetts, United States.

Who is the new Chief Development Officer at Chroma Medicine?
Chroma Medicine named Jenny Marlowe Chief Development Officer, announced May 20, 2024.
What did Chroma Medicine announce on May 20, 2024?
Chroma Medicine, Inc. has announced the appointment of Jenny Marlowe, Ph.D., as the Company's Chief Development Officer
What does Chroma Medicine do?
Chroma Medicine is pioneering a new class of single-dose genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of disease.
Where is Chroma Medicine based?
Chroma Medicine is based in Boston, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Crispr Therapeutics (May 24, 2024), HaemaLogiX (May 20, 2024), Kronos Bio (May 21, 2024) and Atalanta Therapeutics (May 22, 2024) also announced leadership changes within 45 days of Chroma Medicine.

Source: Fundz verified event record.

Other recent leadership changes in Genetics and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Chroma Medicine, and when

A new leader at Chroma Medicine brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Chroma Medicine raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Chroma Medicine, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Chroma Medicine. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Chroma Medicine

Location

Boston, Massachusetts, United States

About

Chroma Medicine is pioneering a new class of single-dose genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of disease. Epigenetics is nature’s central mechanism for gene regulation, governing cell phenotype and function by precisely controlling gene activity without changing the underlying DNA sequence. Building on groundbreaking research from the world’s foremost genomic medicine experts, Chroma Medicine is working at the cutting edge of precision genomics, building an entirely new class of therapeutics to achieve unparalleled control of gene expression. *Note: Be aware of fraudulent recruiting advertisements and scams: Potential candidates for employment at Chroma Medicine should be aware of job offer fraud scams perpetrated through the use of the internet and social media platforms. To learn more, please visit the Join Us page on our website.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Chroma Medicine changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Catherine Stehman-
Likely contact at this company
••••••••@••••••••

See Catherine Stehman-'s verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Chroma Medicine's next move

Learn about Strategic plan

Chroma Medicine changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.